Tags

Type your tag names separated by a space and hit enter

Intensive care unit-acquired weakness: Questions the clinician should ask.
Rev Neurol (Paris). 2022; 178(1-2):84-92.RN

Abstract

Intensive care unit (ICU)-acquired weakness (ICU-AW) is defined as clinically detected weakness in critically ill patients in whom there is no plausible etiology other than critical illness. Using electrophysiological methods, patients with ICU-AW are classified in three subcategories: critical illness polyneuropathy, critical illness myopathy and critical illness neuromyopathy. ICU-AW is a frequent complication occurring in critical ill patients. Risk factors include illness severity and organ failure, age, hyperglycemia, parenteral nutrition, drugs and immobility. Due to short- and long-term complications, ICU-AW results in longer hospital stay and increased mortality. Its management is essentially preventive avoiding modifiable risk factors, especially duration of sedation and immobilization that should be as short as possible. Pharmacological approaches have been studied but none have proven efficacy. In the present review, we propose practical questions that the clinician should ask in case of acquired weakness during ICU stay: when to suspect ICU-AW, what risk factors should be identified, how to diagnose ICU-AW, what is the prognosis and how can recovery be improved?

Authors+Show Affiliations

CHU de Lille, médecine intensive-réanimation, 59000 Lille, France; CHU de Lille, department of clinical neurophysiology, 59000 Lille, France. Electronic address: romain.tortuyaux@chru-lille.fr.CHU de Lille, centre de référence des maladies neuromusculaires, 59000 Lille, France.CHU de Lille, médecine intensive-réanimation, 59000 Lille, France; Université Lille, Inserm U1190, 59000 Lille, France.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

34998522

Citation

Tortuyaux, R, et al. "Intensive Care Unit-acquired Weakness: Questions the Clinician Should Ask." Revue Neurologique, vol. 178, no. 1-2, 2022, pp. 84-92.
Tortuyaux R, Davion JB, Jourdain M. Intensive care unit-acquired weakness: Questions the clinician should ask. Rev Neurol (Paris). 2022;178(1-2):84-92.
Tortuyaux, R., Davion, J. B., & Jourdain, M. (2022). Intensive care unit-acquired weakness: Questions the clinician should ask. Revue Neurologique, 178(1-2), 84-92. https://doi.org/10.1016/j.neurol.2021.12.007
Tortuyaux R, Davion JB, Jourdain M. Intensive Care Unit-acquired Weakness: Questions the Clinician Should Ask. Rev Neurol (Paris). 2022;178(1-2):84-92. PubMed PMID: 34998522.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intensive care unit-acquired weakness: Questions the clinician should ask. AU - Tortuyaux,R, AU - Davion,J-B, AU - Jourdain,M, Y1 - 2022/01/05/ PY - 2021/8/29/received PY - 2021/12/12/revised PY - 2021/12/14/accepted PY - 2022/1/10/pubmed PY - 2022/2/15/medline PY - 2022/1/9/entrez KW - Critical illness polyneuropathy KW - Delayed weaning KW - ICU-acquired weakness KW - Illness severity KW - Neurophysiology SP - 84 EP - 92 JF - Revue neurologique JO - Rev Neurol (Paris) VL - 178 IS - 1-2 N2 - Intensive care unit (ICU)-acquired weakness (ICU-AW) is defined as clinically detected weakness in critically ill patients in whom there is no plausible etiology other than critical illness. Using electrophysiological methods, patients with ICU-AW are classified in three subcategories: critical illness polyneuropathy, critical illness myopathy and critical illness neuromyopathy. ICU-AW is a frequent complication occurring in critical ill patients. Risk factors include illness severity and organ failure, age, hyperglycemia, parenteral nutrition, drugs and immobility. Due to short- and long-term complications, ICU-AW results in longer hospital stay and increased mortality. Its management is essentially preventive avoiding modifiable risk factors, especially duration of sedation and immobilization that should be as short as possible. Pharmacological approaches have been studied but none have proven efficacy. In the present review, we propose practical questions that the clinician should ask in case of acquired weakness during ICU stay: when to suspect ICU-AW, what risk factors should be identified, how to diagnose ICU-AW, what is the prognosis and how can recovery be improved? SN - 0035-3787 UR - https://www.unboundmedicine.com/medline/citation/34998522/Intensive_care_unit_acquired_weakness:_Questions_the_clinician_should_ask_ DB - PRIME DP - Unbound Medicine ER -